OBJECTIVE Familial hyperaldosteronism type II (FH-II) is characterized by inheritance of primary aldosteronism (PAL) but, unlike FH-I, is not glucocorticoid remediable and not associated with the hybrid CYP11B1/CYP11B2 gene mutation. Analysis of two pedigrees previously demonstrated linkage of FH-II with a locus at chromosome 7p22. We sought to determine whether mutations in the exons or intron/exon boundaries in PRKAR1B (encoding protein kinase A regulatory subunit R1-beta), which resides within the linked locus, are associated with FH-II
Primary aldosteronism affects up to 10% of hypertensive patients and is responsible for treatment re...
The genetic basis of most types of adrenal adenomas has been elucidated over the past decade, leadin...
Objectives: The aim of this study was to determine whether mutations in SPINK1/PRSS1 genes are assoc...
Background Familial hyperaldosteronism type II (FH-II) is characterized by the familial occurrence o...
There are two types of familial hyperaldosteronism: FH-I and FH-II. FH-I is caused by a hybrid CYP11...
Primary aldosteronism (PAL) is caused by the autonomous over-production of aldosterone. Once thought...
Once thought rare, primary aldosteronism (PAL) is now reported to be responsible for 5–10% of hypert...
Familial hyperaldosteronism type II (FH-II) is caused by adrenocortical hyperplasia or aldosteronoma...
Primary aldosteronism (PAL) may be as much as ten times more common than has been traditionally thou...
Familial hyperaldosteronism type II (FH-II) is characterized by autosomal dominant inheritance and h...
1. Improved approaches to screening and diagnosis have revealed primary aldosteronism (PAL) to be mu...
Numerous recent reports suggest that primary aldosteronism (PAL) is much more common than previously...
Background Familial hyperaldosteronism type II is a hereditary form of primary aldosteronism not att...
Primary aldosteronism (PA) is a heterogeneous group of disorders caused by the autonomous overproduc...
Primary aldosteronism is the most common form of endocrine hypertension with a prevalence of 6% in t...
Primary aldosteronism affects up to 10% of hypertensive patients and is responsible for treatment re...
The genetic basis of most types of adrenal adenomas has been elucidated over the past decade, leadin...
Objectives: The aim of this study was to determine whether mutations in SPINK1/PRSS1 genes are assoc...
Background Familial hyperaldosteronism type II (FH-II) is characterized by the familial occurrence o...
There are two types of familial hyperaldosteronism: FH-I and FH-II. FH-I is caused by a hybrid CYP11...
Primary aldosteronism (PAL) is caused by the autonomous over-production of aldosterone. Once thought...
Once thought rare, primary aldosteronism (PAL) is now reported to be responsible for 5–10% of hypert...
Familial hyperaldosteronism type II (FH-II) is caused by adrenocortical hyperplasia or aldosteronoma...
Primary aldosteronism (PAL) may be as much as ten times more common than has been traditionally thou...
Familial hyperaldosteronism type II (FH-II) is characterized by autosomal dominant inheritance and h...
1. Improved approaches to screening and diagnosis have revealed primary aldosteronism (PAL) to be mu...
Numerous recent reports suggest that primary aldosteronism (PAL) is much more common than previously...
Background Familial hyperaldosteronism type II is a hereditary form of primary aldosteronism not att...
Primary aldosteronism (PA) is a heterogeneous group of disorders caused by the autonomous overproduc...
Primary aldosteronism is the most common form of endocrine hypertension with a prevalence of 6% in t...
Primary aldosteronism affects up to 10% of hypertensive patients and is responsible for treatment re...
The genetic basis of most types of adrenal adenomas has been elucidated over the past decade, leadin...
Objectives: The aim of this study was to determine whether mutations in SPINK1/PRSS1 genes are assoc...